Correlation between the conformational phenotype of p53 and its subcellular location.

Deppert W , Richards F , Milner J , Patschinsky T
Oncogene 7 ( 7) 1371 -1381

70
1992
FK 506 and cyclosporine A: early effects on activation and gene induction in mouse spleen cells.

F. M. Richards , S. Metcalfe , J. Milner
European Society for Organ Transplantation. Congress. 4 22 ( 4) 1547 -1648

1
1990
Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene

F. M. Richards , S. J. Payne , B. Zbar , N. A. Affara
Human Molecular Genetics 4 ( 11) 2139 -2143

106
1995
Germline E-cadherin Gene (CDH1) Mutations Predispose to Familial Gastric Cancer and Colorectal Cancer

F. M. Richards , S. A. McKee , M. H. Rajpar , T. R. P. Cole
Human Molecular Genetics 8 ( 4) 607 -610

276
1999
Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype.

Paul A.Crossey , Frances M.Richards , Keith Foster , Jane S. reen
Human Molecular Genetics 3 ( 8) 1303 -1308

342
1994
Development of In Vitro Co-Culture Model in Anti-Cancer Drug Development Cascade.

Ruiling Xu , Frances M. Richards
Combinatorial Chemistry & High Throughput Screening 20 ( 5) 451 -457

3
2017
Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours.

PaulA. Crossey , Keith Foster , FrancesM. Richards , MaudeE. Phipps
Human Genetics 93 ( 1) 53 -58

127
1994
Design, synthesis, and biological evaluation of an allosteric inhibitor of HSET that targets cancer cells with supernumerary centrosomes.

Ciorsdaidh A. Watts , Frances M. Richards , Andreas Bender , Peter J. Bond
Chemistry & Biology 20 ( 11) 1399 -1410

66
2013
Germline mutation analysis of the transforming growth factor β receptor type II (TGFBR2) and E-cadherin (CDH1) genes in early onset and familial colorectal cancer

LOVEENA VERMA , TIMOTHY R PORTER , FRANCES M RICHARDS , M HELEN RAJPAR
Journal of Medical Genetics 38 ( 2) e7 -e7

7
2001
Treatment of Macular Degeneration

Frances Margaret Richards , Alan Geoffrey Roach

6
2010
Epigenetic Inactivation of the RASSF1A 3p21.3 Tumor Suppressor Gene in Both Clear Cell and Papillary Renal Cell Carcinoma

Catherine Morrissey , Alonso Martinez , Malgorzata Zatyka , Angelo Agathanggelou
Cancer Research 61 ( 19) 7277 -7281

173
2001
40
1988
Quantifying cell cycle-dependent drug sensitivities in cancer using a high throughput synchronisation and screening approach.

Frances M. Richards , Duncan I. Jodrell , Alan Lau , Timothy I. Johnson
EBioMedicine 68 103396

2021
The ATR Inhibitor AZD6738 Synergizes with Gemcitabine In Vitro and In Vivo to Induce Pancreatic Ductal Adenocarcinoma Regression

Yann Wallez , Charles R. Dunlop , Timothy Isaac Johnson , Siang-Boon Koh
Molecular Cancer Therapeutics 17 ( 8) 1670 -1682

32
2018
Molecular pathology of von Hippel–Lindau disease and the VHL tumour suppressor gene

Frances M. Richards
Expert Reviews in Molecular Medicine 3 ( 08) 1 -27

45
2001
Mapping the Von Hippel — Lindau disease tumour suppressor gene: identification of germline deletions by pulsed field gel electrophoresis

Frances M. Richards , Maude E. Phipps , Farida Latlf , Masahlro Yao
Human Molecular Genetics 2 ( 7) 879 -882

54
1993
Somatic mutations of the von Hippel — Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma

Keith Foster , Amanda Prowse , Anke van den Berg , Stewart Fleming
Human Molecular Genetics 3 ( 12) 2169 -2173

319
1994